Clinical Trial Update: A Trial of Pamiparib With Tislelizumab in Patients With Advanced Tumours With Homologous Recombination Repair Defects [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pamiparib in combination with tislelizumab for advanced tumors with homologous recombination repair defects; status is currently unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Pamiparib (pamiparib)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Cancer | Phase 2 | Status: UNKNOWN